Clinical Trials in Poland

• An Open-Label Extension to Study the Long-Term Effect of Dexpramipexole in Participants with Severe Eosinophilic Asthma (EXHALE-5) Under evaluation
  2024-510810-33-00 Phase III Severe eosinophilic asthma Areteia Therapeutics Inc.
• A Parallel-group (2-Arm), Randomized, Double-blind, 12-week Trial to Evaluate the Efficacy and Safety of MC2-25 Cream and MC2-25 Vehicle in… Not authorised
  2022-500044-38-00 Phase II Chronic Kidney Disease associated Pruritus Mc2 Therapeutics Limited
• ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Not authorised
  2022-500535-36-00 Phase III Moderately to severely active ulcerative colitis Abivax
• ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Not authorised
  2022-500536-11-00 Phase III Moderately to severely active ulcerative colitis Abivax
• ABTECT-Maintenance – ABX464 Treatment Evaluation for ulcerative Colitis Therapy Not authorised
  2022-500537-84-00 Phase III Moderately to severely active ulcerative colitis Abivax
• A phase III, randomised, double-blind, multicentre study comparing the efficacy, safety, and immunogenicity of proposed tocilizumab biosimil… Not authorised
  2022-501361-44-00 Phase III Adult patients of either gender with active moderate to seve… Dr. Reddy's Laboratories Limited
• Clinical trial of MK-7648A in adults and children with skin cancer Not authorised
  2022-501417-31-00 Phase III High-risk Resected Melanoma Merck Sharp & Dohme LLC
• Phase 3 Study Assessing Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Orbit) Not authorised
  2022-501535-16-00 Phase III Atopic Dermatitis (AD) Amgen Inc.
• A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into… Not authorised
  2022-501644-15-00 Phase II Mild Cognitive Impairment due to Alzheimer's Disease Alzheim… Biogen Idec Research Limited
• A clinical study of people with HIV-1 who have not taken antiretroviral therapy, one group will start treatment with a combination of doravi… Not authorised
  2022-502099-22-00 Phase III HIV-1 Infection Merck Sharp & Dohme LLC
• A clinical study of people with HIV-1 who received prior treatment combination of doravirine and islatravir Not authorised
  2022-502126-40-00 Phase III HIV-1 infection Merck Sharp & Dohme LLC
• A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext… Not authorised
  2022-502877-41-00 Phase I/II Pulmonary sarcoidosis with or without extrapulmonary manifes… Xentria Inc.
• Efficacy and Safety of ANB032 in the Treatment of Subjects with Atopic Dermatitis Not authorised
  2023-503522-40-00 Phase II Atopic Dermatitis Anaptysbio Inc.
• Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis Not authorised
  2023-503634-50-00 Phase III Anemia in patients with chronic kidney disease on dialysis Genexine Inc.
• A Study to Learn About the Safety, Tolerability and Blood Levels of a Study Medicine (called sisunatovir) in Infants and Children with RSV L… Not authorised
  2023-504425-39-00 Phase I (Other) Respiratory Syncytial Virus (RSV) Infection Pfizer Inc.
• HARMONi-3 Not authorised
  2023-504989-37-00 Phase III Metastatic Squamous Non-small Cell Lung Cancer Summit Therapeutics Sub Inc.
• A study to assess the efficacy and safety of OATD-01 for the treatment of active pulmonary sarcoidosis. Not authorised
  2023-506642-23-00 Phase II Active Pulmonary Sarcoidosis Molecure S.A.
• Evaluation of treatment effectiveness and safety of somatic cell based therapy for urinary incontinence in patients after radical prostatect… Not authorised
  2023-509812-27-00 Phase I/II urinary incontinence Nicolaus Copernicus University
• "A Clinical Study to Evaluate the Effectiveness of Beltavac® with polymerized extract of grass pollen mixture in allergic rhinoconjunctivit… Not authorised
  2023-510033-28-00 Phase II allergic rhinoconjunctivitis caused due to exposure to polle… Probelte Pharma S.L.
• Phase 3 Study of Telitacicept in Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2) Not authorised
  2024-512716-21-00 Phase III Moderately to Severely Active Systemic Lupus Erythematosus Remegen Co. Ltd.
• EORTC 2237-BCG-QLG: Improvement of Quality of Life through supportive treatments for Endocrine Therapy – related symptoms in patients with e… Not authorised
  2024-513442-10-00 Phase III ER positive HER2 negative breast cancer stages I-II Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europ…
• Pharmacological treatment of compulsive sexual behaviour disorder Not authorised
  2024-514490-22-00 Phase III Compulsive Sexual Behaviour Disorder Centrum Medyczne Ksztalcenia Podyplomowego
• A Randomized, Multicentre, Seamless, Adaptive Phase I/II Study to Determine Safety and Efficacy of RhinoPHAGE-2A cocktail in Patients with C… Not authorised
  2024-516220-34-00 Phase I (FiH) Chronic Rhinosinusitis associated with Staphylococcus aureus… Instytut Immunologii I Terapii Doswiadczalnej Im Ludwika Hirszfelda Pan We Wrocl…
• Study to Evaluate the Efficacy and Safety of ATI-045 in Atopic Dermatitis Not authorised
  2024-520302-19-00 Phase II Atopic dermatitis Aclaris Therapeutics Inc.

Showing 1–24 of 2,673 trials